I would now like to turn the conference over to Stephanie Diaz, Investor Relations. Please go ahead. Stephanie C. Diaz -- President and Chief Executive Officer-Vida Strategic Partners, Inc. Hello, and ...
Viking Therapeutics, Inc. stock has surged nearly 1,500% since 2023, driven by the promising GLP-1/GIP receptor agonist VK-2735 for obesity. VK-2735's Phase 2 data showed weight loss comparable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback